New York, NY -- (SBWIRE) -- 01/19/2018 -- WiseGuyReports.com adds "United States Transdermal Drug Delivery System Market by Manufacturers, States, Type and Application, Forecast to 2022" reports to its Database.

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

Scope of the Report: 
This report focuses on the Transdermal Drug Delivery System in United States market, to split the market based on manufacturers, states, type and application.

Market Segment by Manufacturers, this report covers 
Hisamitsu 
Mylan 
GSK 
Novartis 
Teve (Actavis) 
Johnson & Johnson 
Lohmann 
Teikoku Seiyaku 
Bayer 
Lingrui 
Sanofi 
Qizheng 
Endo 
Huarun 999 
Haw Par 
Nichiban 
Mentholatum Company 
Laboratoires Genevrier

Market Segment by States, covering 
California 
Texas 
New York 
Florida 
Illinois

Market Segment by Type, covers 
Fentanyl 
Nitroglycerin 
Estradiol 
Nicotine 
Other

Market Segment by Applications, can be divided into 
OTC 
Rx

 

 Request For Sample Report @ https://www.wiseguyreports.com/sample-request/2792628-united-states-transdermal-drug-delivery-system-market-by-manufacturers-states                         

                                                                                                                                                        

Table Of Contents

1 Market Overview 
1.1 Transdermal Drug Delivery System Introduction 
1.2 Market Analysis by Type 
1.2.1 Fentanyl 
1.2.2 Nitroglycerin 
1.2.3 Estradiol 
1.2.4 Nicotine 
1.2.5 Other 
1.3 Market Analysis by Applications 
1.3.1 OTC 
1.3.2 Rx 
1.4 Market Analysis by States 
1.4.1 California Status and Prospect (2012-2022) 
1.4.2 Texas Status and Prospect (2012-2022) 
1.4.3 New York Status and Prospect (2012-2022) 
1.4.4 Florida Status and Prospect (2012-2022) 
1.4.5 Illinois Status and Prospect (2012-2022) 
1.5 Market Dynamics 
1.5.1 Market Opportunities 
1.5.2 Market Risk 
1.5.3 Market Driving Force 
2 Manufacturers Profiles 
2.1 Hisamitsu 
2.1.1 Profile 
2.1.2 Transdermal Drug Delivery System Type and Applications 
2.1.3 Hisamitsu Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 
2.1.4 Business Overview 
2.1.5 Hisamitsu News 
2.2 Mylan 
2.2.1 Profile 
2.2.2 Transdermal Drug Delivery System Type and Applications 
2.2.3 Mylan Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 
2.2.4 Business Overview 
2.2.5 Mylan News 
2.3 GSK 
2.3.1 Profile 
2.3.2 Transdermal Drug Delivery System Type and Applications 
2.3.3 GSK Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 
2.3.4 Business Overview 
2.3.5 GSK News 
2.4 Novartis 
2.4.1 Profile 
2.4.2 Transdermal Drug Delivery System Type and Applications 
2.4.3 Novartis Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 
2.4.4 Business Overview 
2.4.5 Novartis News 
2.5 Teve (Actavis) 
2.5.1 Profile 
2.5.2 Transdermal Drug Delivery System Type and Applications 
2.5.3 Teve (Actavis) Transdermal Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 
2.5.4 Business Overview 
2.5.5 Teve (Actavis) News 

 

 Continued…….

Complete Report Details @ https://www.wiseguyreports.com/reports/2792628-united-states-transdermal-drug-delivery-system-market-by-manufacturers-states